系统性红斑狼疮患者β细胞功能受损
多变量分析显示SLE患者裂解胰岛素原水平升高,裂解胰岛素原/胰岛素比值在糖皮质激素治疗与否均上调,且SLE损伤评分与完整及裂解胰岛素原水平独立相关。结论提示SLE患者存在β细胞功能紊乱,高胰岛素原血症可由疾病损伤解释且不依赖泼尼松使用。
要点
- SLE患者裂解胰岛素原水平高于匹配对照,且不依赖糖皮质激素使用。
- 裂解胰岛素原/胰岛素比值在SLE患者中上调,糖皮质激素治疗与否均显著。
- SLE损伤评分与完整及裂解胰岛素原水平独立相关,不依赖泼尼松使用。
核心结论
- SLE患者存在胰岛素原加工代谢物上调,提示β细胞功能紊乱。
- 这种高胰岛素原血症可由疾病损伤解释,且独立于泼尼松使用。
研究设计与样本
- 检测胰岛素、裂解及完整胰岛素原和C肽水平,并进行多变量回归分析。
- 分析调整了糖皮质激素摄入和胰岛素抵抗经典危险因素。
主要发现
- SLE患者裂解胰岛素原水平高于对照,无论是否使用糖皮质激素。
- 裂解胰岛素原/胰岛素比值在糖皮质激素治疗组β=0.19(95%CI 0.07,0.30),P=0.002;未治疗组β=0.09(95%CI 0.01,0.17),P=0.025。
- 完整胰岛素原/胰岛素比值仅在糖皮质激素治疗组显著,β=0.08(95%CI 0.03,0.12),P=0.001。
- SLE损伤评分与完整胰岛素原β=0.51 pmol/l(95%CI 0.17,0.86),P=0.004及裂解胰岛素原β=1.65 pmol/l(95%CI 0.24,3.06),P=0.022相关。
临床怎么用
- 对SLE患者应关注β细胞功能紊乱,尤其高疾病损伤评分者。
- 糖皮质激素使用与否均需考虑胰岛素原加工异常,评估代谢风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate how markers of beta-cell secretion (proinsulin-processing metabolites) are expressed in SLE patients and their potential relation to features associated with the disease such as activity or damage. METHODS: One hundred and forty-four SLE patients and 69 nondiabetic sex- and age-matched controls were assessed. Beta-cell secretion molecules, as measured by insulin, split and intact proinsulins, and C-peptide levels were analysed in both groups. Multiple regression analysis was performed to compare proinsulin propeptides between groups and to explore the interrelations with SLE features. Analyses were adjusted for glucocorticoid intake and for insulin resistance classic risk factors. RESULTS: Fully multivariable analysis demonstrated that regardless of glucocorticoid use, SLE patients exhibited higher levels of split proinsulin. Likewise, the split proinsulin-to-insulin ratio was upregulated in patients with SLE undergoing glucocorticoid therapy [beta coeficient 0.19 (95% Confidence Interval 0.07, 0.30), P = 0.002] or not [beta coef. 0.09 (95% CI: 0.01, 0.17), P = 0.025]. Similar results were found for the intact proinsulin-to-insulin ratio, although differences were only statistically significant for patients taking glucocorticoids [beta coef. 0.08 (95% CI: 0.03, 0.12), P = 0.001]. SLE damage score was associated with higher serum levels of intact [beta coef. 0.51 (95% CI 0.17, 0.86) pmol/l, P = 0.004] and split proinsulins [beta coef. 1.65 (95% CI 0.24, 3.06) pmol/l, P = 0.022] after multivariable analysis, including disease duration and prednisone use. CONCLUSION: Among patients with SLE, proinsulin-processing metabolites, a marker of beta-cell disruption, are upregulated compared with matched controls. This disproportionate hyperproinsulinemia can be explained by the damage produced by the disease and occurs independently of prednisone use.
引用
- García-Dorta A, Quevedo-Abeledo JC, Rua-Figueroa Í, et al. Beta-cell function is disrupted in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2021. PMID: 33369681. doi:10.1093/rheumatology/keaa874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。